Motasim Masood

ORCID: 0000-0003-1499-3114
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Occupational and environmental lung diseases
  • Prostate Cancer Treatment and Research
  • Neuroendocrine Tumor Research Advances
  • Ubiquitin and proteasome pathways
  • Protein Degradation and Inhibitors
  • Wnt/β-catenin signaling in development and cancer
  • Gestational Trophoblastic Disease Studies
  • Genetic factors in colorectal cancer
  • Hormonal and reproductive studies
  • Ferroptosis and cancer prognosis
  • Estrogen and related hormone effects
  • Endoplasmic Reticulum Stress and Disease
  • Chromatin Remodeling and Cancer
  • Urinary and Genital Oncology Studies
  • CRISPR and Genetic Engineering

Hammersmith Hospital
2024

Imperial College London
2015-2024

Resistance to docetaxel is a major clinical problem in advanced prostate cancer (PCa). Although glucocorticoids (GCs) are frequently used combination with docetaxel, it unclear what extent GCs and their receptor, the glucocorticoid receptor (GR), contribute chemotherapy resistance. In this study, we aim elucidate role of GR docetaxel-resistant PCa order improve current therapies. expression was analyzed tissue microarray primary specimens from chemonaive docetaxel-treated patients, cultured...

10.1530/erc-15-0343 article EN cc-by Endocrine Related Cancer 2015-10-19

Abstract STK11 adnexal tumour is a recently described female genital tract tumour, usually identified in paratubal location, often associated with Peutz-Jeghers syndrome (PJS) and gene alterations most of the cases. Morphologically, this composed cells arranged variety patterns, including cords, trabeculae, tubules cystic acinar structures. The are only moderately pleomorphic mitotic activity variable. As express epithelial, sex cord stromal mesothelial markers, may be stromal, epithelial or...

10.1007/s00428-024-03763-2 article EN cc-by Virchows Archiv 2024-02-20

Abstract Background When ectopically overexpressed, anticancer genes, such as TRAIL , PAR4 and ORCTL3 specifically destroy tumour cells without harming untransformed cells. Anticancer genes can not only serve powerful specific therapy tools but studying their mode of action reveal mechanisms underlying the neoplastic transformation, sustenance spread. Methods gene discovery is normally accidental. Here we describe a systematic, gain function, forward genetic screen in mammalian to isolate...

10.1186/s12964-023-01300-3 article EN cc-by Cell Communication and Signaling 2023-10-20
Coming Soon ...